TY - JOUR AU - Tognoni, Gianni T1 - Dai Nobel per l’economia 2019,
una rilettura delle metodologie sperimentali
e non di produzione della conoscenza PY - 2019 Y1 - 2019-10-01 DO - 10.1702/3273.32396 JO - Assistenza Infermieristica e Ricerca JA - Assist Inferm Ric VL - 38 IS - 4 SP - 192 EP - 199 PB - Il Pensiero Scientifico Editore SN - 2038-1778 Y2 - 2026/04/24 UR - http://dx.doi.org/10.1702/3273.32396 N2 - Summary. From Nobel Prize for economy 2019 to a re-appraisal of experimental and not experimental methods for producing knowledge. The assignment of the 2019 Nobel prize of medicine to three investigators for their work on the assessment of the cost/effectiveness of health care strategies has been motivated with a more than surprising statement: their 'discovery and pilot application of an innovative methodology' in the production of reliable knowledge: the randomised controlled trial (RCT). For all those who operate in the area of health care (and do since decades rely on RCTs in the pursuit of evidence based practice), the surprise cannot be left without an in depth reflection on the whys and on the implications of a decision which is certainly an indicator of the well known ambiguity of the growing and conflicting criteria which are assumed as guidance in the assessment of health care strategies: economic and financial sustainability is challenging and substituting the access to the universal right to evidence based care. A tentative methodological and cultural- political answer to the challenge is proposed through a critical (model, obviously not exhaustive) exploration of the most qualified medical literature made available in the months around the assignment of the Nobel prize, to underline the gaps which must be faced to assure a comprehensive care centered on the unmet human, social, medical needs, where the (difficult!) interplay of economic and health exigencies should be sought with policies and strategies for which RCT are only a very partial unsatisfactory response. ER -